These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 6572834

  • 21. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW, Diao LD, Yan XL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [Abstract] [Full Text] [Related]

  • 22. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A, Giorgi-Rossi P, Sangalli M, Spadea T, Perucci CA.
    Ann Ig; 2002 Aug; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract] [Full Text] [Related]

  • 23. [A serological study on the immunization schedule at first dose of domestic BRD II strain rubella vaccine].
    Xu AQ, Song LZ, Hao SZ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Jun; 18(3):156-9. PubMed ID: 9812464
    [Abstract] [Full Text] [Related]

  • 24. Progress in measles and rubella elimination in Iran.
    Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
    Pourabbas B, Ziyaeyan M, Alborzi A, Mardaneh J.
    Int J Infect Dis; 2008 Jan; 12(1):43-6. PubMed ID: 17950020
    [Abstract] [Full Text] [Related]

  • 26. [Necessity and strategy of rubella vaccination].
    Sandow D, Gerike E, Rasch G, Rosmus K.
    Z Arztl Fortbild (Jena); 1990 Jan; 84(8):373-5. PubMed ID: 2378119
    [No Abstract] [Full Text] [Related]

  • 27. [Rubella monitoring in Norway].
    Lystad A.
    Nord Med; 1990 Jan; 105(6-7):195. PubMed ID: 2367193
    [Abstract] [Full Text] [Related]

  • 28. Inadvertent rubella vaccination of pregnant women: evaluation of possible transplacental infection with rubella vaccine.
    Hamkar R, Jalilvand S, Abdolbaghi MH, Esteghamati AR, Hagh-Goo A, Jelyani KN, Mohktari-Azad T, Zahraei M, Nategh R.
    Vaccine; 2006 Apr 24; 24(17):3558-63. PubMed ID: 16510217
    [Abstract] [Full Text] [Related]

  • 29. [Rubella in Poland in 2002].
    Czarkowski MP, Rosińska M.
    Przegl Epidemiol; 2004 Apr 24; 58(1):49-55. PubMed ID: 15218643
    [Abstract] [Full Text] [Related]

  • 30. [Rubella in Poland in 2003].
    Czarkowski MP, Stefanoff P.
    Przegl Epidemiol; 2005 Apr 24; 59(2):215-21. PubMed ID: 16190523
    [Abstract] [Full Text] [Related]

  • 31. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G.
    Przegl Epidemiol; 2003 Apr 24; 57(2):281-8. PubMed ID: 12910596
    [Abstract] [Full Text] [Related]

  • 32. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S, Kakarriqi E, Xibinaku M, Ion-Nedelcu N, Bukli M, Emiroglu N, Uzicanin A.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [Abstract] [Full Text] [Related]

  • 33. [Rubella in Poland in 2001].
    Czarkowski MP, Sitarska-Gołebiowska J.
    Przegl Epidemiol; 2003 May 15; 57(1):49-55. PubMed ID: 12926310
    [Abstract] [Full Text] [Related]

  • 34. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
    Haas DM, Flowers CA, Congdon CL.
    Obstet Gynecol; 2005 Aug 15; 106(2):295-300. PubMed ID: 16055578
    [Abstract] [Full Text] [Related]

  • 35. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 01; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 37. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.
    France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R, Vaccine Safety Datalink Team.
    Pediatrics; 2008 Mar 01; 121(3):e687-92. PubMed ID: 18310189
    [Abstract] [Full Text] [Related]

  • 38. Seroprevalence of rubella among Jordanian women of childbearing age.
    Jarour N, Hayajneh WA, Balbeesi A, Otoom H, Al-Shurman A, Kharabsheh S.
    Vaccine; 2007 May 04; 25(18):3615-8. PubMed ID: 17280747
    [Abstract] [Full Text] [Related]

  • 39. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.
    Minussi L, Mohrdieck R, Bercini M, Ranieri T, Sanseverino MT, Momino W, Callegari-Jacques SM, Schuler-Faccini L.
    Reprod Toxicol; 2008 Jan 04; 25(1):120-3. PubMed ID: 17977696
    [Abstract] [Full Text] [Related]

  • 40. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.